Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: Cases from Mansoura, Egypt

References

• Friedmann AM, Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist 2000;5:321–328.
   PubMedGoogle Scholar
• Hashino S, Imamura M. Clinical application gene technology for diagnosis and treatment of leukemia. Rinsho Byori January 1997;45(1):58–65.
   PubMedGoogle Scholar
• Heim S, Smeland EB. Molecular genetic diagnosis of leukemia and lymphoma. Tidsskr Nor Laegeforen 1998;118(16): 2511–2518.
   PubMedGoogle Scholar
• Donadieu J, Hill C. Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: A methodological review. Br j Haematol 2001;115 (1):34–45.
   PubMed Web of Science ®Google Scholar
• Avet-Loiseau H. FISH analysis at diagnosis in acute lymphoblastic leukemia. Leuk Lymphoma 1999;33:441.
   PubMed Web of Science ®Google Scholar
• Joyce CA, Ross FM, Dennis NR, et al. Multipaint FISH: A rapid and reliable way to define cryptic and complex abnormalities. Clin Genet 1999;56:192–199.
   PubMed Web of Science ®Google Scholar
• Lanzowsky P. Leukemia: Manual of pediatric haematology and oncology. 3rd ed. 2000. p 359–409, Academic press, San Diego, San Francisco, New York, Boston, London, Sydney and Tokyo.
   Google Scholar
• SPSS: Statistical package for social science. standard version 10.0 Chicago, IL: SPSS Inc. 1999.
   Google Scholar
• Luken J. Acute lymphocytic leukemia. In: Lee GR, Buthell TL, Athens JW, Leuken JN, editors. Wintrobe’s clinical haematology. 9th ed. Philadelphia, London: Lea and Febiger; 1993. p 1892–1919.
   Google Scholar
• Steinherz PG, Gaynon PS, Breneman JC, et al. Cytoreduction and prognosis in acute lymphoblastic leukemia; the import-ance of early marrow response: Report from the children’s cancer group. J Clin Oncol 1996;14:389–398.
   PubMed Web of Science ®Google Scholar
• Nachman J, Sather FIN, Gaynon PS, et al. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: A report from the children’s cancer group. J Clin Oncol 1997;15: 2222–2230.
   PubMed Web of Science ®Google Scholar
• Smith M, Arthur D, Camitta B, et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin oncol 1996;14(1):18–24.
   PubMed Web of Science ®Google Scholar
• Sather HN, Miller D, Nesbit M, et al. Difference in prognosis for boys and girls with acute lymphoblastic leukemia. Lancet 1981;1:739.
   PubMed Web of Science ®Google Scholar
• Chessells JM, Richards SM, Bailey CC, et al. Gender and treatment outcome in childhood lymphoblastic leukemia: Report from the MRC UKALL trials. Br J Haematol 1995; 89(2):364–372.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Li X. A population-based study of familial soft tissue tumors. J Clin Epidemiol 2001;54 (4):411–416.
   PubMed Web of Science ®Google Scholar
• Hammond D, Sather H, Nesbit M, et al. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol 1986;14:124–134.
   PubMedGoogle Scholar
• Eguiguren JM, Schell MJ, Crist WM, et al. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992;79:871.
   PubMed Web of Science ®Google Scholar
• Miller DR. Acute lymphoblastic leukemia. Pediatr Clin North Am 1980;27:269–275.
   PubMed Web of Science ®Google Scholar
• Ibrahim WN, Sabry FH, Saleh AT, et al. Surface markers analysis and correlation with FAB classification in Egyptian infants and children with acute lymphoblastic leukemia (ALL). Egypt J Haematol 1988;13(1-2):19–25.
   Google Scholar
• Baehner RI,, Miller DR. Haematologic malignancies: Leuke-mia and lymphoma. In: Bacher RL, Miller DR, Camphel WM, editors. Blood diseases of infancy and childhood. 5th ed. Missouri: CV Mosby Company; 1984. p 619–721.
   Google Scholar
• Khalifa AS, Mokhtar GM, Gaballah M, et al. Clinico-epidemiological study of acute childhood leukemia in Egypt. Egypt J Haematol 1988;13(3-4):167–188.
   Google Scholar
• Khalifa AS, Mokhtar GM, Al OF, et al. Behaviour of acute childhood leukemia in Egypt. Egypt J oncol 1982;2:27.
   Google Scholar
• Miller DR, Kraile M, Blever WA, et al. Prognostic implications of blast cells morphology in childhood acute lymphoblastic leukemia. A report from the children’s cancer study group. Cancer Treat Rep 1985;69:1211–1281.
   PubMedGoogle Scholar
• Van Eys J, Pullen J, Head D, et al. The French American British (FAB) classification of leukemia. The paediatric oncology group experience with lymphocytic leukemia. Cancer 1986;57:1046–1052.
   Google Scholar
• Miller DR, Leikin S, Albo V, Sather H, Hammond D. Prognostic importance of morphology (FAB classification) in childhood acute lymphoblastic leukaemia (ALL). Br J Haematol 1981;48(2):199–206.
   PubMed Web of Science ®Google Scholar
• Lflleyman JS, Hann IM, Stevens RF, Eden OB, Richards SM. French American British (FAB) morphological classification of childhood lymphoblastic leukemia and its clinical import-ance. J Clin Pathol 1986;39(9):998–1002.
   PubMed Web of Science ®Google Scholar
• Pui CH, Raimondi SC, Grist WM. Chromosomal abnormal-ities in childhood acute lymphoblastic leukemia. In: Hoffbrand AV, Brenner MK, editors. Recent advances in hematology. 6th ed. 1992. p 89–105, Churchill Livingstone, Edinburgh, London, Madrid, Melbourne, New York, and Tokyo.
   Google Scholar
• Seeker-Walker LM, Lawler SD, Hardisty RM. Prognostic implications of chromosomal findings in acute lymphoblastic leukemia at diagnosis. Br Med J 1978;2(6151):1529–1530.
   PubMed Web of Science ®Google Scholar
• Pui CH, Grist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 1990;76:1449–1463.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Rowley JD, Veriajojis D, et al. Correlation of karyotype with clinical features in acute lymphoblastic leukemia. Cancer Res 1982;42:2918.
   PubMed Web of Science ®Google Scholar
• Fletcher JA, Kimball VM, Lynch E, et al. Prognosis implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia. Blood 1989;74:2130.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Maseki N, Homma C, et al. Clinical significance of chromosome abnormalities in childhood acute lympho-blastic leukemia in Japan. Leukemia 1994;8 (11):1930–1944.
   Web of Science ®Google Scholar
• Hafez M, Mansour AK, Mahmoud LA, et al. Clinical significance of chromosome abnormalities in children with acute lymphoblastic leukemia. Egypt J Haematol 1999;24.
   Google Scholar
• Rowley JD, Reshmi S, Carlson K, et al. Spectral karyotype analysis of T-cell acute leukemia. Blood 1999;93:2038.
   PubMed Web of Science ®Google Scholar
• Viehmann S, Burkhardt A, Lampert F, et al. Multiplex PCR a rapid screening method for detection of gene rearrangements in childhood acute lymphoblastic leukemia. Ann Hematol 1999;78:157.
   PubMed Web of Science ®Google Scholar
• Bloomfield CD, Lindquist LL, Arthur D, et al. Clinical significance of chromosomal abnormalities in acute lympho-blastic leukemia. Cancer Res 1981;41:4838.
   PubMed Web of Science ®Google Scholar
• Secker-Walker LM, Swansbury GJ, Lawler SD. Cytogenetics of acute lymphobalstic leukemia in children as a factor in prediction of long-term survival. Br J Hematol 1982;52:389.
   PubMed Web of Science ®Google Scholar
• Micallef-Eynaud PD, Eden OB, Grace E, et al. Cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1993;10:25.
   PubMed Web of Science ®Google Scholar
• Heerma NA, Nachman JB, Sather HN, et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the children’s cancer group. Blood 1999;94(12):4036–4045.
   PubMed Web of Science ®Google Scholar
• Bloomfield CD, Seeker-Walker LM, Goldman AT. Six year follow up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet 1989;40: 171–189.
   PubMed Web of Science ®Google Scholar
• Seeker-Walker LM, Goldman JM. Cytogenetics and leuke-mogenesis. In: Hoffbrand AV, Lewis SM, editors. Postgradu-ate hematology. London: Heineman Professional Publishing Ltd 1989; p 359.
   Google Scholar
• Ito C, Kumagai M, Manabe A, et al. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis. Blood 1999;93(1):315–320.
   PubMed Web of Science ®Google Scholar
• Mehdipour P, Mirfakhraie R, Jahani M, Mehdipour AR. Karyotypic evolution: Cytogenetics follow-up study in child-hood acute lymphoblastic leukemia. Asian Pac J Cancer Prey 2003;4(4):358–368.
   PubMedGoogle Scholar
• Nordgren A, Nordenskjld M, Mac Donald A, et al. A case of acute lymphoblastic leukemia, near-triploidy, and poor outcome. Cancer Genet Cytogenet 1997;99(2):93–96.
   PubMed Web of Science ®Google Scholar
• Zemanova Z, Michalova K, Sindelarova L, et al. Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia. Leuk Res 2005;29(3):273–281.
   PubMed Web of Science ®Google Scholar
• Stark B, Jeison M, Gobuzov R, et al. Near haploid childhood acute lymphoblastic leukemia masked by hyperdiploid line: Detection by fluorescence in situ hybridization. Cancer Genet Cytogenet 2001;128(2):108–113.
   PubMed Web of Science ®Google Scholar
• Harrison CJ, Moorman AV, Broadfield ZJ, et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia. Br J Hematol 2004;125(5):552–559.
   PubMed Web of Science ®Google Scholar
• Harris MB, Shuster JJ, Andrew SA, et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure. A pediatric oncology group study. Blood 1992;79:3316–3324.
   Google Scholar
• Watson MS, Carrell AJ, Shuster JJ, et al. Trisomy 21 in childhood acute lymphoblastic leukemia. A pediatric oncology group study. Blood 1993;82:3098–3102.
   Google Scholar
• Berger R. Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet 1997;94 (1):8–12.
   PubMed Web of Science ®Google Scholar
• Williams DL, Harber J, Murphy SB, et al. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 1986;68:205.
   PubMed Web of Science ®Google Scholar
• Williams DL, Harris A, Williams KG, et al. A direct bone marrow chromosome technique for acute lymphoblastic leukemia. Cancer Genet Cytogenet 1984;13:239.
   PubMed Web of Science ®Google Scholar
• Morrison-Delap S, BS UW. Waisman center cytogenetics laboratory. In: Heim S, Mitelman F, editors. Cancer cytogenetics. 2nd ed. 2000, from internet April 3.
   Google Scholar
• Hafez M, El-Tahan H, El-Morsi Z, et al. Genetic environ-mental interaction in acute lymphatic leukemia. In: Muller HJ, Weber W, editors. Familial cancer. 1985. p 161–166, Basel, Munchen, Paris, London, New York, New Delhi, Singapore, Tokyo, Sidney.
   Google Scholar
• Pui CH. Childhood leukemias. N Engl J Med 1995;332:1618.
   PubMed Web of Science ®Google Scholar
• Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996;88:2375.
   PubMed Web of Science ®Google Scholar
• Bartolo C, Viswanatha DS. Molecular diagnosis in pediatric acute leukemia. Clin North Am 2000;20:139–156.
   Google Scholar
• Ariffin H, Chen SP, Wong HL, Yeoh A. Validation of a multiplex RT-PCR assay for screening significant oncogene fusion transcripts in children with acute lymphoblastic leukaemia. Singapore Med J 2003;44(10):517–520.
   PubMedGoogle Scholar
• Kantarjian HM, Diesseroth A, Kurzrock M, et al. Chronic myelogenous leukemia: A concise up-date. Blood 1993; 82:691.
   PubMed Web of Science ®Google Scholar
• Foroni L, Harrison CJ, Hoffbrand AV, et al. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukemia by molecular analysis. Br J Haematol 1999;105(1):7–24.
   PubMed Web of Science ®Google Scholar
• Baker SJ, Fearon ER, Wilson JKV, etal. Suppression of human colorectal carcinoma cell growth by wild-type P53. Science 1990;249:912.
   PubMed Web of Science ®Google Scholar
• Wada M, Bartram C, Nakamura H, et al. Analysis of P53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 1993;82:3163.
   PubMed Web of Science ®Google Scholar
• Maroni G. Cancer: a genetic disease in molecular and genetic analysis of human traits. Chapter 8, 2001. p 229–230.
   Google Scholar
• Grist WM, Carroll AJ, Shuster JJ, et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A pediatric oncology group study. Blood 1990;76:117–122.
   PubMed Web of Science ®Google Scholar
• Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993;81: 2386–2393.
   PubMed Web of Science ®Google Scholar
• Behm FG, Raimondi SC, Frestedt JL, et al. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age. Blood 1996;87:2870–2877.
   PubMed Web of Science ®Google Scholar